Tempus Announces New ctDNA Assay, xF Monitor
Tumor uninformed treatment response monitoring assay for research use only November 03, 2023 01:00 PM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced xF...